ONTOLOGY REPORT - ANNOTATIONS
Term: Multiple Sclerosis
Accession: RDO:0006150
browse the term
Definition: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
Synonyms: exact_synonym: DISSEMINATED SCLEROSIS MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1; Disseminated Sclerosis; MS; MS (Multiple Sclerosis); MS1; MS2; MS3; MS4; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4; Multiple Sclerosis, Acute Fulminating
primary_id: MESH:D009103
alt_id: OMIM:107741 ; OMIM:126200 ; OMIM:612594 ; OMIM:612595 ; OMIM:612596
Multiple Sclerosis
G
Acan
aggrecan
ISS
1
134,787,341
134,848,992
RGD:2315836
RGD
G
Ache
acetylcholinesterase
ISS
RGD:5688127
RGD
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISS
11
79,908,291
79,911,065
RGD:5686885
RGD
G
Ager
advanced glycosylation end product-specific receptor
ISS
20
4,250,613
4,253,540
RGD:6767562
RGD
G
Apoa1
apolipoprotein A-I
ISS
RGD:5508215
RGD
G
Apoc2
apolipoprotein C-II
ISS
1
78,979,034
78,984,002
RGD:1358408
RGD
G
Apoe
apolipoprotein E
IEA
1
79,003,634
79,006,387
RGD:1331525
RGD
G
Apoe
apolipoprotein E
ISS
1
79,003,634
79,006,387
RGD:7240710
OMIM
G
Bdnf
brain-derived neurotrophic factor
Onset
ISS
RGD:5684915
RGD
G
Cacna1b
calcium channel, voltage-dependent, N type, alpha 1B subunit
ISS
3
2,842,948
3,039,747
RGD:1580151
RGD
G
Ccl5
chemokine (C-C motif) ligand 5
ISS
10
71,605,791
71,610,330
RGD:4890028
RGD
G
Ccl7
chemokine (C-C motif) ligand 7
ISS
10
70,267,281
70,269,131
RGD:6483814
RGD
G
Ccl7
chemokine (C-C motif) ligand 7
ISS
10
70,267,281
70,269,131
RGD:6483818
RGD
G
Ccr3
chemokine (C-C motif) receptor 3
ISS
8
128,759,943
128,769,341
RGD:6892919
RGD
G
Ccr5
chemokine (C-C motif) receptor 5
ISS
8
128,907,157
128,912,272
RGD:1358460
RGD
G
Cd24
CD24 molecule
ISS
20
47,502,354
47,507,663
RGD:1358462
RGD
G
Cd28
Cd28 molecule
ISS
9
59,342,273
59,367,743
RGD:1358478
RGD
G
Cd40
CD40 molecule, TNF receptor superfamily member 5
Susceptibility
ISS
3
156,092,602
156,107,427
RGD:5490971
RGD
G
Cd40
CD40 molecule, TNF receptor superfamily member 5
Susceptibility
ISS
3
156,092,602
156,107,427
RGD:5490975
RGD
G
Cd46
CD46 molecule, complement regulatory protein
ISS
13
110,972,812
111,003,407
RGD:6483460
RGD
G
Cfh
complement factor H
No_Association
ISS
13
53,252,249
53,355,987
RGD:5684555
RGD
G
Ciita
class II, major histocompatibility complex, transactivator
Susceptibility
ISS
10
5,087,174
5,133,418
RGD:1358146
RGD
G
Ciita
class II, major histocompatibility complex, transactivator
No_Association
ISS
10
5,087,174
5,133,418
RGD:5491189
RGD
G
Ciita
class II, major histocompatibility complex, transactivator
ISS
10
5,087,174
5,133,418
RGD:5491175
RGD
G
Clec16a
C-type lectin domain family 16, member A
ISS
10
4,870,719
5,069,691
RGD:5491175
RGD
G
Cmpk2
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial
ISS
6
44,128,544
44,139,346
RGD:5133255
RGD
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISS
10
89,519,421
89,525,978
RGD:6483346
RGD
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISS
10
89,519,421
89,525,978
RGD:6483339
RGD
G
Cntf
ciliary neurotrophic factor
Onset
ISS
1
215,842,668
215,844,691
RGD:1626112
RGD
G
Col1a1
collagen, type I, alpha 1
ISS
10
83,622,438
83,639,368
RGD:5688302
RGD
G
Cst3
cystatin C
ISS
3
137,650,903
137,654,776
RGD:5686392
RGD
G
Cst3
cystatin C
ISS
3
137,650,903
137,654,776
RGD:5686394
RGD
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
No_Association
ISS
9
59,495,773
59,501,300
RGD:2301975
RGD
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISS
9
59,495,773
59,501,300
RGD:1358538
RGD
G
Ctsb
cathepsin B
ISS
15
42,402,829
42,423,701
RGD:5686392
RGD
G
Ctsb
cathepsin B
ISS
15
42,402,829
42,423,701
RGD:5686395
RGD
G
Ctsh
cathepsin H
ISS
8
94,971,689
94,990,434
RGD:5686392
RGD
G
Ctsl1
cathepsin L1
ISS
17
6,288,013
6,294,174
RGD:5686392
RGD
G
Faslg
Fas ligand (TNF superfamily, member 6)
ISS
13
77,472,950
77,480,210
RGD:1358622
RGD
G
Fcgr2a
Fc fragment of IgG, low affinity IIa, receptor
No_Association
ISS
13
86,898,651
86,911,743
RGD:5147977
RGD
G
Fcgr3a
Fc fragment of IgG, low affinity IIIa, receptor
Disease_progression
ISS
13
86,867,641
86,877,665
RGD:5508375
RGD
G
Gabra3
gamma-aminobutyric acid (GABA) A receptor, alpha 3
ISS
X
158,405,509
158,633,501
RGD:1358628
RGD
G
Gc
group specific component
No_Association
ISS
14
20,166,243
20,197,060
RGD:5509887
RGD
G
Gc
group specific component
ISS
14
20,166,243
20,197,060
RGD:5509923
RGD
G
Gc
group specific component
ISS
14
20,166,243
20,197,060
RGD:5509922
RGD
G
Gc
group specific component
Susceptibility
ISS
14
20,166,243
20,197,060
RGD:5509885
RGD
G
Grm8
glutamate receptor, metabotropic 8
ISS
4
53,976,781
54,902,331
RGD:6771187
RGD
G
Grn
granulin
ISS
10
91,536,135
91,542,239
RGD:5509591
RGD
G
Gstm1
glutathione S-transferase mu 1
Disease_progression
ISS
2
203,575,444
203,580,821
RGD:5490267
RGD
G
Gstm3
glutathione S-transferase mu 3
Disease_progression
ISS
2
203,532,363
203,537,135
RGD:5490267
RGD
G
Gstp1
glutathione S-transferase pi 1
Disease_progression
ISS
1
206,627,398
206,629,866
RGD:5490267
RGD
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
ISS
5
167,093,827
167,125,298
RGD:6784513
RGD
G
Hsp90ab1
heat shock protein 90 alpha (cytosolic), class B member 1
ISS
9
11,033,496
11,038,868
RGD:5686803
RGD
G
Hspa8
heat shock 70kDa protein 8
ISS
8
43,784,035
43,787,760
RGD:6480236
RGD
G
Ifng
interferon gamma
ISS
7
57,621,756
57,625,792
RGD:1358738
RGD
G
Igf2
insulin-like growth factor 2
ISS
1
202,906,624
202,915,231
RGD:5510017
RGD
G
Il12a
interleukin 12A
ISS
2
158,710,261
158,717,689
RGD:724447
RGD
G
Il13
interleukin 13
ISS
10
39,093,512
39,096,069
RGD:5684368
RGD
G
Il1b
interleukin 1 beta
ISS
3
116,964,422
116,970,867
RGD:1358741
RGD
G
Il1rn
interleukin 1 receptor antagonist
ISS
3
2,607,800
2,613,216
RGD:1358741
RGD
G
Il21r
interleukin 21 receptor
ISS
1
184,665,737
184,693,583
RGD:6892695
RGD
G
Il21r
interleukin 21 receptor
ISS
1
184,665,737
184,693,583
RGD:6892963
RGD
G
Il2ra
interleukin 2 receptor, alpha
ISS
17
78,050,491
78,097,802
RGD:2311526
RGD
G
Il4
interleukin 4
ISS
10
39,074,582
39,080,134
RGD:1358745
RGD
G
Il4r
interleukin 4 receptor
ISS
1
184,612,903
184,637,863
RGD:4890395
RGD
G
Il4r
interleukin 4 receptor
IAGP
1
184,612,903
184,637,863
RGD:1358313
RGD
G
Il6
interleukin 6
ISS
4
456,799
461,376
RGD:1358318
RGD
G
Jag1
jagged 1
ISS
3
125,181,063
125,216,481
RGD:6482240
RGD
G
Jag1
jagged 1
Disease_progression
ISS
3
125,181,063
125,216,481
RGD:6482233
RGD
G
Klk6
kallikrein related-peptidase 6
ISS
1
94,254,350
94,261,500
RGD:2314867
RGD
G
Mbp
myelin basic protein
TAS
18
78,943,608
79,057,329
RGD:1358773
RGD
G
Mbp
myelin basic protein
ISS
18
78,943,608
79,057,329
RGD:1358488
RGD
G
Mphosph9
M-phase phosphoprotein 9
Susceptibility
ISS
12
33,394,159
33,457,830
RGD:2316985
RGD
G
Mpo
myeloperoxidase
ISS
10
76,085,872
76,097,012
RGD:1358499
RGD
G
Mt-atp6
mitochondrially encoded ATP synthase 6
ISS
MT
7,919
8,599
RGD:5490263
RGD
G
Mt-atp6
mitochondrially encoded ATP synthase 6
ISS
MT
7,919
8,599
RGD:5490259
RGD
G
Mt-atp8
mitochondrially encoded ATP synthase 8
ISS
MT
7,758
7,961
RGD:5490263
RGD
G
Mt-nd1
mitochondrially encoded NADH dehydrogenase 1
ISS
MT
2,740
3,694
RGD:5490252
RGD
G
Mt-nd2
mitochondrially encoded NADH dehydrogenase 2
ISS
MT
3,904
4,942
RGD:5490259
RGD
G
Ndufs2
NADH dehydrogenase (ubiquinone) Fe-S protein 2
ISS
13
87,124,431
87,137,497
RGD:6482255
RGD
G
Ngfr
nerve growth factor receptor
ISS
10
84,262,804
84,281,006
RGD:5508481
RGD
G
Notch4
notch 4
ISS
20
4,263,205
4,287,312
RGD:6480692
RGD
G
Phactr2
phosphatase and actin regulator 2
ISS
1
7,988,527
8,102,667
RGD:6483093
RGD
G
Pla2g7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
ISS
9
13,057,988
13,100,289
RGD:6482783
RGD
G
Pnmt
phenylethanolamine-N-methyltransferase
ISS
RGD:1358561
RGD
G
Prf1
perforin 1 (pore forming protein)
ISS
20
28,658,367
28,663,877
RGD:6482805
RGD
G
Prf1
perforin 1 (pore forming protein)
ISS
20
28,658,367
28,663,877
RGD:6482820
RGD
G
Prf1
perforin 1 (pore forming protein)
ISS
20
28,658,367
28,663,877
RGD:6482817
RGD
G
Psmb9
proteasome (prosome, macropain) subunit, beta type, 9
ISS
20
4,801,187
4,806,608
RGD:6483446
RGD
G
Ptprc
protein tyrosine phosphatase, receptor type, C
ISS
13
51,246,163
51,357,995
RGD:1358566
RGD
G
Pvrl2
poliovirus receptor-related 2
No_Association
ISS
1
79,021,831
79,059,686
RGD:6767565
RGD
G
Pvrl2
poliovirus receptor-related 2
Severity
ISS
1
79,021,831
79,059,686
RGD:6767558
RGD
G
Rhoa
ras homolog family member A
ISS
RGD:2298887
RGD
G
RT1-Ba
RT1 class II, locus Ba
Susceptibility
ISS
20
4,697,971
4,702,564
RGD:5147555
RGD
G
RT1-Bb
RT1 class II, locus Bb
Susceptibility
ISS
20
4,730,559
4,736,201
RGD:5147658
RGD
G
RT1-Bb
RT1 class II, locus Bb
Susceptibility
ISS
20
4,730,559
4,736,201
RGD:5147555
RGD
G
RT1-Da
RT1 class II, locus Da
ISS
20
4,636,310
4,641,282
RGD:5490204
RGD
G
RT1-Da
RT1 class II, locus Da
ISS
20
4,636,310
4,641,282
RGD:5490202
RGD
G
RT1-Db1
RT1 class II, locus Db1
Susceptibility
ISS
20
4,671,489
4,681,058
RGD:5147580
RGD
G
RT1-Db1
RT1 class II, locus Db1
ISS
20
4,671,489
4,681,058
RGD:5147581
RGD
G
RT1-Db1
RT1 class II, locus Db1
Onset
ISS
20
4,671,489
4,681,058
RGD:5147573
RGD
G
RT1-Db1
RT1 class II, locus Db1
Susceptibility
ISS
20
4,671,489
4,681,058
RGD:5147564
RGD
G
RT1-Db1
RT1 class II, locus Db1
Susceptibility
ISS
20
4,671,489
4,681,058
RGD:5147559
RGD
G
RT1-Db1
RT1 class II, locus Db1
Susceptibility
ISS
20
4,671,489
4,681,058
RGD:5147555
RGD
G
Sh2d2a
SH2 domain containing 2A
ISS
2
179,916,108
179,924,623
RGD:1358573
RGD
G
Slc11a1
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1
ISS
9
73,714,692
73,725,523
RGD:5684937
RGD
G
Slc11a1
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1
No_Association
ISS
9
73,714,692
73,725,523
RGD:5684960
RGD
G
Spp1
secreted phosphoprotein 1
ISS
RGD:1581329
RGD
G
Spp1
secreted phosphoprotein 1
ISS
RGD:1581472
RGD
G
Tap2
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
No_Association
ISS
20
4,770,446
4,784,488
RGD:6482281
RGD
G
Tap2
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
Susceptibility
ISS
20
4,770,446
4,784,488
RGD:6482279
RGD
G
Tap2
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
Spontaneous
ISS
20
4,770,446
4,784,488
RGD:6482280
RGD
G
Tlr4
toll-like receptor 4
ISS
5
83,564,100
83,577,735
RGD:2312575
RGD
G
Tnfsf9
tumor necrosis factor (ligand) superfamily, member 9
ISS
RGD:2317352
RGD
G
Vdr
vitamin D (1,25- dihydroxyvitamin D3) receptor
IEA
7
136,567,614
136,617,280
RGD:1331525
RGD
G
Vdr
vitamin D (1,25- dihydroxyvitamin D3) receptor
Susceptibility
ISS
7
136,567,614
136,617,280
RGD:5147559
RGD
G
Vegfa
vascular endothelial growth factor A
ISS
9
10,520,730
10,536,071
RGD:634255
RGD
Q
Eae1
Experimental allergic encephalomyelitis QTL 1
IED
20
4,740,609
6,880,472
RGD:61031
RGD
Q
Eae10
Experimental allergic encephalomyelitis QTL 10
IED
14
19,142,085
19,800,225
RGD:61031
RGD
Q
Eae11
Experimental allergic encephalomyelitis QTL 11
IED
4
32,648,616
36,592,773
RGD:61031
RGD
Q
Eae12
Experimental allergic encephalomyelitis QTL 12
IED
10
96,667,338
105,886,241
RGD:69695
RGD
Q
Eae13
Experimental allergic encephalomyelitis QTL 13
IED
12
25,367,251
37,906,389
RGD:69695
RGD
Q
Eae14
Experimental allergic encephalomyelitis QTL 14
IED
13
24,701,710
69,701,710
RGD:69695
RGD
Q
Eae15
Experimental allergic encephalomyelitis QTL 15
IED
18
79,585,008
80,370,517
RGD:69695
RGD
Q
Eae16
Experimental allergic encephalomyelitis QTL 16
IAGP
8
8,294,860
115,338,082
RGD:629629
RGD
Q
Eae17
Experimental allergic encephalomyelitis QTL 17
IAGP
13
28,645,448
106,366,082
RGD:629629
RGD
Q
Eae18a
Experimental allergic encephalomyelitis QTL 18a
QTM
10
54,594,018
60,865,280
RGD:1302437
RGD
Q
Eae18b
Experimental allergic encephalomyelitis QTL 18b
QTM
10
67,774,947
71,067,824
RGD:1302437
RGD
Q
Eae2
Experimental allergic encephalomyelitis QTL 2
IED
4
17,617,956
36,592,773
RGD:69694
RGD
Q
Eae23
Experimental allergic encephalomyelitis QTL 23
Induced
IAGP
10
57,438,568
63,167,167
RGD:2293859
RGD
Q
Eae24
Experimental allergic encephalomyelitis QTL 24
IAGP
4
65,821,936
71,729,738
RGD:2317591
RGD
Q
Eae25
Experimental allergic encephalomyelitis QTL 25
IAGP
4
78,039,509
82,266,081
RGD:2317591
RGD
Q
Eae26
Experimental allergic encephalomyelitis QTL 26
IAGP
4
88,462,327
104,416,171
RGD:2317591
RGD
Q
Eae27
Experimental allergic encephalomyelitis QTL 27
IAGP
4
104,415,992
114,074,165
RGD:2317591
RGD
Q
Eae29
Experimental allergic encephalomyelitis QTL 29
IAGP
1
6,253,932
25,271,177
RGD:4888518
RGD
Q
Eae3
Experimental allergic encephalomyelitis QTL 3
IED
10
27,184,741
67,678,060
RGD:69694
RGD
Q
Eae30
Experimental allergic encephalomyelitis QTL 30
IAGP
1
124,308,081
130,290,315
RGD:6892695
RGD
Q
Eae31
Experimental allergic encephalomyelitis QTL 31
IAGP
1
183,163,129
193,070,197
RGD:6892695
RGD
Q
Eae32
Experimental allergic encephalomyelitis QTL 32
IAGP
17
33,277,173
42,659,723
RGD:4889889
RGD
Q
Eae33
Experimental allergic encephalomyelitis QTL 33
IAGP
17
59,104,847
66,993,271
RGD:4889889
RGD
Q
Eae4
Experimental allergic encephalomyelitis QTL 4
IED
9
1,526,958
22,066,101
RGD:69712
RGD
Q
Eae5
Experimental allergic encephalomyelitis QTL 5
IED
12
20,932,559
24,470,522
RGD:61031
RGD
Q
Eae6
Experimental allergic encephalomyelitis QTL 6
IED
1
176,854,992
186,472,032
RGD:61031
RGD
Q
Eae7
Experimental allergic encephalomyelitis QTL 7
IED
1
240,980,142
247,322,277
RGD:61031
RGD
Q
Eae8
Experimental allergic encephalomyelitis QTL 8
IED
19
26,534,809
34,998,604
RGD:61031
RGD
Q
Eae9
Experimental allergic encephalomyelitis QTL 9
IED
6
127,683,728
147,636,619
RGD:61031
RGD
Q
Eaex
Experimental allergic encephalomyelitis QTL x
IED
5
57,974,567
102,974,567
RGD:61031
RGD
Q
Eaey
Experimental allergic encephalomyelitis QTL y
IED
18
49,034,213
87,265,094
RGD:61031
RGD
Q
Eaez
Experimental allergic encephalomyelitis QTL z
IED
18
13,239,641
58,239,641
RGD:61031
RGD
Q
Pia41
Pristane induced arthritis QTL 41
IAGP
1
183,163,129
185,328,208
RGD:6892695
RGD
S
BUF/N
TAS
RGD:1004
RGD
S
DA
DA
TAS
RGD:1004
RGD
S
DA.BN-(D9Wox17-D9Got15 )/Kini
IED
9
1,526,762
6,948,180
RGD:7241236
RGD
S
DA.BN-(D9Wox24-D9Rat44 )/Kini
Resistance
IED
9
2,948,882
2,949,051
RGD:7241236
RGD
S
Kini:DA,PVG-G10
Induced
IAGP
RGD:2293859
RGD
S
LEW
Lewis
TAS
RGD:1004
RGD
S
LEW.BN-(D9Got8-D9Got22 )/Kini
IED
9
3,811,425
12,324,010
RGD:7241236
RGD
S
PVG
PVG
TAS
RGD:1004
RGD
S
PVG.LEW-(D1Rat270-D1Rat68 )/Kini
IAGP
1
130,290,073
193,070,197
RGD:6892695
RGD
Multiple Sclerosis, Chronic Progressive
G
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif, 14
ISS
20
28,555,684
28,631,824
RGD:6771190
RGD
G
Bche
butyrylcholinesterase
ISS
2
164,329,613
164,427,994
RGD:5687690
RGD
G
Cd274
CD274 molecule
Severity
ISS
1
233,053,607
233,065,384
RGD:6893669
RGD
G
Gc
group specific component
ISS
14
20,166,243
20,197,060
RGD:5509869
RGD
G
Grn
granulin
Susceptibility
ISS
10
91,536,135
91,542,239
RGD:5509596
RGD
G
Grn
granulin
ISS
10
91,536,135
91,542,239
RGD:5509591
RGD
G
Igfbp3
insulin-like growth factor binding protein 3
Disease_progression
ISS
14
87,959,153
87,967,085
RGD:1626118
RGD
G
RT1-Db1
RT1 class II, locus Db1
Severity
ISS
20
4,671,489
4,681,058
RGD:5147610
RGD
Multiple Sclerosis, Relapsing-Remitting
G
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif, 14
ISS
20
28,555,684
28,631,824
RGD:6771190
RGD
G
Apoa4
apolipoprotein A-IV
Onset
ISS
8
49,233,142
49,233,431
RGD:5685649
RGD
G
Cd36
CD36 molecule (thrombospondin receptor)
ISS
4
13,471,878
13,525,620
RGD:6893496
RGD
G
Cd80
Cd80 molecule
ISS
11
64,045,358
64,070,072
RGD:6893670
RGD
G
Cspg4
chondroitin sulfate proteoglycan 4
ISS
8
60,610,835
60,645,877
RGD:5686865
RGD
G
Ctss
cathepsin S
ISS
2
190,425,290
190,466,877
RGD:5687146
RGD
G
Grn
granulin
Disease_progression
ISS
10
91,536,135
91,542,239
RGD:5509591
RGD
G
Havcr1
hepatitis A virus cellular receptor 1
ISS
10
31,834,519
31,858,019
RGD:5128853
RGD
G
Hspa8
heat shock 70kDa protein 8
ISS
8
43,784,035
43,787,760
RGD:5688780
RGD
G
Klc1
kinesin light chain 1
Susceptibility
ISS
6
136,553,146
136,586,393
RGD:5684008
RGD
G
Mmp19
matrix metallopeptidase 19
ISS
7
2,091,532
2,099,235
RGD:1642025
RGD
G
S100b
S100 calcium binding protein B
ISS
20
12,791,440
12,824,508
RGD:5508822
RGD
Neuromyelitis Optica
G
Aqp4
aquaporin 4
ISS
18
6,626,313
6,642,766
RGD:5148024
RGD
G
Aqp4
aquaporin 4
ISS
18
6,626,313
6,642,766
RGD:5148032
RGD
G
RT1-Db1
RT1 class II, locus Db1
ISS
20
4,671,489
4,681,058
RGD:5147590
RGD
G
S100b
S100 calcium binding protein B
ISS
20
12,791,440
12,824,508
RGD:5508767
RGD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest